hVIVO PLC has appointed Caroline Shaw as an independent non-executive director starting October 1. Shaw will chair the remuneration committee and join the audit committee, bringing over 30 years of healthcare leadership experience. She replaces Elaine Sullivan, who is stepping down after serving since 2020 and contributing to the company's strategic transformation. The board expects Shaw's expertise to support hVIVO's expansion of its clinical development platform.
The story concerns hVIVO's board changes. For readers following the health sector, here is Pluang's market snapshot as of Sep 22, 2026 12:31 WIB: Among 95 priced US health stocks, 43 rose and 49 fell. Notable movers include WGS at USD 97.00 with a -4.06% change and 100% buy order activity, CTXR at USD 0.58 with a -3.92% change and 97% buy order activity, and ENVB at USD 1.56 with a -3.70% change and 100% sell order activity.
Former BitMEX CEO Arthur Hayes suggests that a drop in AI investment could indirectly support Bitcoin by causing financial strain on heavily leveraged AI infrastructure projects, such as data centers and semiconductor purchases. This strain might imp...
Edge Total Intelligence Inc. was selected as one of 10 finalists in the ATI Horizons Maritime Manufacturing Innovation Challenge, which aims to modernize US maritime capabilities aligned with the Navy's advanced manufacturing strategy. The company’s ...
Ethena's governance token ENA surged 71.14% from $0.135 to $0.231 in early September, driven by strong demand for its synthetic stablecoin USDe and significant staking activity totaling nearly $1.26 billion. Despite Bitcoin's breakout, ENA stalled ar...
Power Metallic Mines announced new assay results from its Summer 2026 drill program, revealing high-grade copper and precious metals at depths up to 800 meters, well below previous resource estimates. The deep drilling confirmed that the Lion deposit...
Kingfisher PLC has started the third tranche of its £300 million share buyback program, allocating up to £50 million to repurchase shares for cancellation. Morgan Stanley will independently execute the purchases from now until 15 December 2026. This ...
